InsulinGlargineonset iswithin 3to 4hrBinds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.NovologInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.controlhyperglycemiain pts withT1/T2 DM.AlbuterolSulfate Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Treatment&prevention ofbronchospasmin asthma andCOPD.Caution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.antidiabetic,long-actinginsulinPO/inhalationObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Basaglar,Lantus,ToujouExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumAdminister oralmed with mealsto minimizegastric irritationonset iswithin15minInsulinApartShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Instruct ptsto contactHCPimmediatelyof SOB.pancreaticAssess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Antidiabetics,rapid actinginsulinsExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.Administersubq within 5-10min beforemeal. Rotateinjection sites.Bronchodilators;adrenergicSCInsulinGlargineonset iswithin 3to 4hrBinds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.NovologInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.controlhyperglycemiain pts withT1/T2 DM.AlbuterolSulfate Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Treatment&prevention ofbronchospasmin asthma andCOPD.Caution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.antidiabetic,long-actinginsulinPO/inhalationObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Basaglar,Lantus,ToujouExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumAdminister oralmed with mealsto minimizegastric irritationonset iswithin15minInsulinApartShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Instruct ptsto contactHCPimmediatelyof SOB.pancreaticAssess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Antidiabetics,rapid actinginsulinsExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.Administersubq within 5-10min beforemeal. Rotateinjection sites.Bronchodilators;adrenergicSC

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. Insulin Glargine
  2. onset is within 3 to 4hr
  3. Binds to beta 2 adrenergic receptors in airway smooth muscle by inhibiting phosphorylation of myosin and decrease intracellular calcium leads to relaxation of smooth muscle airways.
  4. Do not draw up dose into a syringe from the kiwi pens, syringe markings do not match up and could lead to medication error. Prior to withdrawing dose, rotate vial btw palms to ensure uniform solution; do not shae.
  5. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  6. hypoglycemia, hypokalemia, erythema, lipodystrophy, pruritus, swelling.
  7. Do not mix insulin Glargine with other insulin. If giving with a short acting insulin, use separate syringes and diff injection sites.
  8. Novolog
  9. Inform pts of unusual bad taste. Advise pts to rinse mouth after each inhalation to minimize dry mouth.
  10. control hyperglycemia in pts with T1/T2 DM.
  11. Albuterol Sulfate
  12. Instruct pts on proper techniques for admin. Demonstrate technique for mixing insulins by drawing up insulin Aspart first.
  13. chest pain, palpitations, nervousness, restlessness, tremor, paradoxical bronchospasm w/excessive use.
  14. Treatment &prevention of bronchospasm in asthma and COPD.
  15. Caution pt not to exceed recommended dose, may cause adverse effects or loss of effectiveness of med.
  16. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  17. Monitor pulmonary function test before initiating therapy and periodically during therapy.
  18. antidiabetic, long-acting insulin
  19. PO/inhalation
  20. Observe for paradoxical bronchospasm (wheezing). Notify HCP immediately if condition occurs.
  21. Basaglar, Lantus, Toujou
  22. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  23. Monitor for hypokalemia as albuterol may cause a decrease in serum potassium
  24. Administer oral med with meals to minimize gastric irritation
  25. onset is within 15min
  26. Insulin Apart
  27. Shake inhaler well and allow at least 1min btw inhalations. Prime inhaler before first use by releasing 4 test sprays.
  28. Instruct pts to contact HCP immediately of SOB.
  29. pancreatic
  30. Assess lung sounds, pulse, BP before admin and during peak of med. Note amount, color, and character of sputum produced.
  31. Antidiabetics, rapid acting insulins
  32. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  33. Stimulate glucose uptake in skeletal muscle and fat, inhibit hepatic glucose production.
  34. Administer subq within 5-10min before meal. Rotate injection sites.
  35. Bronchodilators; adrenergic
  36. SC